Cargando…

Metabolic profiling in children and young adults with autosomal dominant polycystic kidney disease

Autosomal dominant polycystic kidney disease (ADPKD) is the most commonly inherited kidney disease. Although children with ADPKD show normal renal function, cyst development is already occurring. In this study, we aimed to identify markers and associated molecular pathways of disease progression in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baliga, Madhurima M., Klawitter, Jost, Christians, Uwe, Hopp, Katharina, Chonchol, Michel, Gitomer, Berenice Y., Cadnapaphornchai, Melissa A., Klawitter, Jelena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988179/ https://www.ncbi.nlm.nih.gov/pubmed/33758231 http://dx.doi.org/10.1038/s41598-021-84609-8

Ejemplares similares

Effects of lovastatin treatment on the metabolic distributions in the Han:SPRD rat model of polycystic kidney disease
por: Klawitter, Jelena, et al.
Publicado: (2013)

Curcumin therapy to treat vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease: Design and baseline characteristics of participants
por: Nowak, Kristen L., et al.
Publicado: (2020)

Affected parent sex and severity of autosomal dominant polycystic kidney disease: a retrospective cohort study
por: Nowak, Kristen L., et al.
Publicado: (2018)

The tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression
por: Nguyen, Dustin T., et al.
Publicado: (2023)

Clinical Trials in Pediatric Autosomal Dominant Polycystic Kidney Disease
por: Cadnapaphornchai, Melissa A.
Publicado: (2017)

CD8(+) T cells modulate autosomal dominant polycystic kidney disease progression
por: Kleczko, Emily K., et al.
Publicado: (2018)

Weight loss and cystic disease progression in autosomal dominant polycystic kidney disease
por: Hopp, Katharina, et al.
Publicado: (2021)

Developments in the management of autosomal dominant polycystic kidney disease
por: Masoumi, Amirali, et al.
Publicado: (2008)

Hypertension in young adults with autosomal dominant polycystic kidney disease: a case for early screening?
por: Cadnapaphornchai, Melissa A, et al.
Publicado: (2023)

Mitochondrial cyclophilin D ablation is associated with the activation of Akt/p70S6K pathway in the mouse kidney
por: Klawitter, Jelena, et al.
Publicado: (2017)

Imaging Biomarkers in Young Patients With ADPKD
por: Yang, Xinyi, et al.
Publicado: (2023)

Effects of lovastatin on breast cancer cells: a proteo-metabonomic study
por: Klawitter, Jelena, et al.
Publicado: (2010)

Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients
por: Hanudel, Mark R., et al.
Publicado: (2019)

Mycophenolate Mofetil Enhances the Negative Effects of Sirolimus and Tacrolimus on Rat Kidney Cell Metabolism
por: Klawitter, Jelena, et al.
Publicado: (2014)

Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) Studies
por: Nowak, Kristen L., et al.
Publicado: (2021)

Structural Identification of Zotarolimus (ABT-578) Metabolites Generated by Human Liver Microsomes Using Ion-Trap and High-Resolution Time-of-Flight Mass Spectrometry in Combination with the Analysis of Fragmentation Patterns
por: Shokati, Touraj, et al.
Publicado: (2023)

Autosomal dominant polycystic kidney disease in young adults
por: Martínez, Víctor, et al.
Publicado: (2022)

A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney Disease
por: Perrone, Ronald D., et al.
Publicado: (2017)

Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022)

International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people
por: Gimpel, Charlotte, et al.
Publicado: (2019)

Prevalence of pericardial effusion in autosomal dominant polycystic kidney disease
por: Jost, Johanna Sophia, et al.
Publicado: (2023)

Immune checkpoint activity regulates polycystic kidney disease progression
por: Kleczko, Emily K., et al.
Publicado: (2023)

Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial
por: Alloway, Rita R., et al.
Publicado: (2017)

Autosomal dominant polycystic kidney disease in Colombia
por: Camargo, Jessica T., et al.
Publicado: (2023)

Everolimus and Sirolimus in Combination with Cyclosporine Have Different Effects on Renal Metabolism in the Rat
por: Bohra, Rahul, et al.
Publicado: (2012)

Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
por: Perrone, Ronald D., et al.
Publicado: (2017)

Kidney volume and function in autosomal dominant polycystic kidney disease
por: Higashihara, Eiji, et al.
Publicado: (2013)

Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)
por: Sans-Atxer, Laia, et al.
Publicado: (2013)

Nephrotic syndrome and autosomal dominant polycystic kidney disease
por: Visciano, Bianca, et al.
Publicado: (2012)

Umbilical hernia in autosomal dominant polycystic kidney disease
por: Hattori, Yoshinari, et al.
Publicado: (2014)

Diagnostic Imaging of Autosomal Dominant Polycystic Kidney Disease
por: Gradzik, Monika, et al.
Publicado: (2016)

Obturator hernia in autosomal dominant polycystic kidney disease
por: Jung, Jong Hwan, et al.
Publicado: (2018)

Autosomal dominant polycystic kidney disease: updated perspectives
por: Rastogi, Anjay, et al.
Publicado: (2019)

Educational Case: Autosomal Dominant Polycystic Kidney Disease
por: Frazier, Ryan L., et al.
Publicado: (2020)

Cerebral Microbleeds in Autosomal Dominant Polycystic Kidney Disease
por: Tsai, Li-Kai, et al.
Publicado: (2020)

Clinical burden of autosomal dominant polycystic kidney disease
por: Hung, Peir-Haur, et al.
Publicado: (2020)

Drug management of autosomal dominant polycystic kidney disease
por: Theivendran, Thiveya, et al.
Publicado: (2022)

Tolvaptan use in children and adolescents with autosomal dominant polycystic kidney disease: rationale and design of a two-part, randomized, double-blind, placebo-controlled trial
por: Schaefer, Franz, et al.
Publicado: (2019)

Renal disease progression in autosomal dominant polycystic kidney disease
por: Higashihara, Eiji, et al.
Publicado: (2012)

Bilateral emphysematous pyelonephritis in autosomal dominant polycystic kidney disease
por: Lakshminarayana, G., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_008m339i7972g56r9rs76o8f22